Association study between genetic variants at the VAMP2 and VAMP3 loci and bipolar affective disorder

Psychiatric Genetics

Volumn 18, Issue 4, 2008, Pages 199-203

  Jamra, Rami Abou ^a   Gobina, Carl Motinda ^a   Becker, Tim ^a   Georgi, Alexander ^b   Schulze, Thomas G ^b   Schmael, Christine ^b   Cichon, Sven ^a   Propping, Peter ^a   Rietschel, Marcella ^b   Nöthen, Markus M ^a   Schumacher, Johannes ^a  

^a UNIVERSITY OF BONN   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

17q; 1p; Case control; D serine; German; SNARE

Indexed keywords

CELLUBREVIN; SYNAPTOBREVIN 2; VAMP2 PROTEIN, HUMAN; VAMP3 PROTEIN, HUMAN;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; BIPOLAR DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2; VESICLE-ASSOCIATED MEMBRANE PROTEIN 3;

EID: 50349100071     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283050a83     Document Type: Article

References (22)

1. Abou Jamra R, Schmael C, Cichon S, Rietschel M, Schumacher J, Nothen MM (2006). The G72/G30 gene locus in psychiatric disorders: a challenge to diagnostic boundaries? Schizophr Bull 32:599-608.
2. Armitage P (1955). Tests for linear trends in proportions and frequencies. Biometrics 11:375-386.
3. Becker T, Knapp M (2004). Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 27:21-32.
4. Becker T, Cichon S, Jönson E, Knapp M (2005a). Multiple testing in the context of haplotype analysis revisited: application to case-control data. Ann Hum Genet 69:747-756.
5. Becker T, Schumacher J, Cichon S, Baur MP, Knapp M (2005b). Haplotype interaction analysis of unlinked regions. Genet Epidemiol 29:313-322.
6. Chen YS, Akula N, Detera-Wadleigh SD, Schulze TG, Thomas J, Potash JB, et al. (2004). Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol Psychiatry 9:87-92.
7. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, et al. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 99:13675-13680.
8. Fangerau H, Ohlraun S, Granath RO, Nothen MM, Rietschel M, Schulze TG (2004). Computer-assisted phenotype characterisation for genetic research in psychiatry. Hum Hered 58:122-130.
9. First MB, Frances AJ, Pincus HA, Vettorello N, Davis WW (1994). DSM-IV in progress. Changes in substance-related, schizophrenic, and other primarily adult disorders. Hosp Community Psychiatry 45:18-20.
10. Hattori E, Liu C, Badner JA, Bonner TI, Christian SL, Maheshwari M, et al. (2003). Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 72:1131-1140.
11. Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y, Dahary D, et al. (2004). Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 56:169-176.
12. Krystal JH, D'Souza DC, Petrakis IL, Belger A, Berman RM, Charney DS, et al. (1999). NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry 7:125-143.
13. McGuffin P, Farmer AE, Harvey I (1991). A polydiagnostic application of the operational criteria in studies of psychotic illness. Arch Gen Psychiatry 48:764-770.
14. Mothet JP, Pollegioni L, Ouanounou G, Martineau M, Fossier P, Baux G (2005). Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine. Proc Natl Acad Sci U S A 102:5606-5611.
15. Purcell S, Cherny SS, Sham PC (2003). Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150.
16. Schiffer HH (2002). Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders? Mol Neurobiol 25:191-212.
17. Schulze TG, McMahon FJ (2004). Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum Hered 58: 131-138.
18. Schulze TG, Ohlraun S, Czerski PM, Schumacher J, Kassem L, Deschner M, et al. (2005). Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry 162:2101-2108.
19. Schumacher J, Jamra RA, Freudenberg J, Becker T, Ohlraun S, Otte AC, et al. (2004). Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 9:203-207.
20. Schumacher J, Kaneva R, Jamra RA, Diaz GO, Ohlraun S, Milanova V, et al. (2005). Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provide further evidence of loci on chromosome 4q31 and 6q24. Am J Hum Genet 77:1102-1111.
21. Tamminga C (1999). Glutamatergic aspects of schizophrenia. Br J Psychiatry 37 (Suppl):12-15.
22. Tsai G, Lane HY, Yang P, Chong MY, Lange N (2004). Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 55:452-456.